yep CSL112 will be massive. and IMO after the aegisII trial, I reckon there will be trials of whether it will be able to be used as a prophylactic agent to reduce LDL instead of just for preventing a reccurent MI - and that could be absolutely massive as it would have the same market as statins.
short csl, page-31
-
- There are more pages in this discussion • 249 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$292.60 |
Change
-2.610(0.88%) |
Mkt cap ! $141.3B | |||
| Open | High | Low | Value | Volume |
| $293.17 | $293.93 | $291.50 | $177.3M | 606.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1768 | $292.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $292.65 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |